Biocytogen

China
Shuanghejiedao, Sichuan, China
781-587-3558 ★

Company profile

Biocytogen company profile

Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

Business identity

Contact email
[email protected]
Phone number
781-587-3558
Operating status
Active
Company type
For Profit
Employee range
01001-05000 employees
Revenue range
$100K+
Founded
2008-11-01

Headquarters

Headquarters
Shuanghejiedao, Sichuan, China
Postal code
102609
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
7
Total equity funding
$335.2M
Last funding
Post Ipo Equity / $49.8M / 2022-08-19
Last equity funding
Post Ipo Equity / $49.8M
Investors
14
Lead investors
3
Founders
1
Articles
86
Exited on
2022-09-01

Founders and investors

Founders

Yuelei Shen

Lead investors

China Life Healthcare FundCMB International Capital CorporationSDIC Venture Capital

Investors

3E BioventuresCowin CapitalCPEOrbiMedRemegen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.